Cargando…

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

Detalles Bibliográficos
Autores principales:	Staels, Bart, Fonseca, Vivian A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Diabetes Progression, Prevention, and Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811459/ https://www.ncbi.nlm.nih.gov/pubmed/19875558 http://dx.doi.org/10.2337/dc09-S355

Ejemplares similares

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Bile Acid Sequestrants for Lipid and Glucose Control
por: Staels, Bart, et al.
Publicado: (2010)

Defining and Characterizing the Progression of Type 2 Diabetes
por: Fonseca, Vivian A.
Publicado: (2009)

Soaping Up Type 2 Diabetes With Bile Acids?: The Link Between Glucose and Bile Acid Metabolism in Humans Tightens: Quality Matters!
por: Staels, Bart, et al.
Publicado: (2013)

The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
por: Kumar, Aditi, et al.
Publicado: (2022)

Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials
por: Hansen, Morten, et al.
Publicado: (2012)

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2009)

Incretin-Based Therapies: Viewpoints on the way to consensus
por: Nauck, Michael. A., et al.
Publicado: (2009)

Goals of Treatment for Type 2 Diabetes: β-Cell preservation for glycemic control
por: Marchetti, Piero, et al.
Publicado: (2009)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Changing the Treatment Paradigm for Type 2 Diabetes
por: Del Prato, Stefano, et al.
Publicado: (2009)

Viewpoints on the Way to the Consensus Session: Where does insulin resistance start? The adipose tissue
por: Iozzo, Patricia
Publicado: (2009)

Target for Glycemic Control: Concentrating on glucose
por: Monnier, Louis, et al.
Publicado: (2009)

Insulin Therapy for Type 2 Diabetes
por: Swinnen, Sanne G., et al.
Publicado: (2009)

Early Insulin Treatment in Type 2 Diabetes: What are the pros?
por: Meneghini, Luigi F.
Publicado: (2009)

Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy
por: Garber, Alan J.
Publicado: (2009)

Where Does Insulin Resistance Start?: The brain
por: Pagotto, Uberto
Publicado: (2009)

Early Insulin Use in Type 2 Diabetes: What are the cons?
por: Chiasson, Jean-Louis
Publicado: (2009)

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2009)

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2009)

Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
por: Perseghin, Gianluca
Publicado: (2009)

Telemedical Artificial Pancreas: PARIS (Páncreas Artificial Telemédico Inteligente) research project
por: de Leiva, Alberto, et al.
Publicado: (2009)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
por: Boutati, Eleni I., et al.
Publicado: (2009)

Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
por: Tuomilehto, Jaakko
Publicado: (2009)

Bile Acid Sequestrants Based on Natural and Synthetic Gels
por: Stanciu, Magdalena-Cristina, et al.
Publicado: (2023)

OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019)

Effects of Bile Acid Modulation by Dietary Fat, Cholecystectomy, and Bile Acid Sequestrant on Energy, Glucose, and Lipid Metabolism and Gut Microbiota in Mice
por: Park, Sunmin, et al.
Publicado: (2022)

Plasma bile acids are not associated with energy metabolism in humans
por: Brufau, Gemma, et al.
Publicado: (2010)

The Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes
por: Smushkin, Galina, et al.
Publicado: (2013)

Myostatin Knockout Regulates Bile Acid Metabolism by Promoting Bile Acid Synthesis in Cattle
por: Wu, Di, et al.
Publicado: (2022)

Bile Acid-Induced Virulence Gene Expression of Vibrio parahaemolyticus Reveals a Novel Therapeutic Potential for Bile Acid Sequestrants
por: Gotoh, Kazuyoshi, et al.
Publicado: (2010)

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)

SAT-655 Bile Acid Sequestration Synergistically Accelerates Glucagon Receptor-Stimulated Body Weight Loss in Diet-Induced Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2020)

Regulation of Bile Acid and Cholesterol Metabolism by PPARs
por: Li, Tiangang, et al.
Publicado: (2009)

A case of COVID-19 diarrhea relieved by bile acid sequestrant administration
por: Shirohata, Akira, et al.
Publicado: (2022)

Bile acid sequestrants in poor healing after endoscopic therapy of Barrett’s esophagus
por: Welsch, Lukas, et al.
Publicado: (2023)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

XXIII international bile acid meeting: Bile acids as signal integrators and metabolic modulators
por: Eapen, C. E.
Publicado: (2017)

MON-163 Lowering of Circulating FGF21 by Modulation of Bile Acid Metabolism in Healthy Males
por: Al-Khaifi, Amani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dnskto4nvvmo69bd53ek6oac16